269 related articles for article (PubMed ID: 31241430)
1. Protein Post-Translational Modification Crosstalk in Acute Myeloid Leukemia Calls for Action.
Hernandez-Valladares M; Wangen R; Berven FS; Guldbrandsen A
Curr Med Chem; 2019; 26(28):5317-5337. PubMed ID: 31241430
[TBL] [Abstract][Full Text] [Related]
2. Freezing effects on the acute myeloid leukemia cell proteome and phosphoproteome revealed using optimal quantitative workflows.
Aasebø E; Mjaavatten O; Vaudel M; Farag Y; Selheim F; Berven F; Bruserud Ø; Hernandez-Valladares M
J Proteomics; 2016 Aug; 145():214-225. PubMed ID: 27107777
[TBL] [Abstract][Full Text] [Related]
3. Decoding Post-Translational Modification Crosstalk With Proteomics.
Leutert M; Entwisle SW; Villén J
Mol Cell Proteomics; 2021; 20():100129. PubMed ID: 34339852
[TBL] [Abstract][Full Text] [Related]
4. FAIMS Enhances the Detection of PTM Crosstalk Sites.
Adoni KR; Cunningham DL; Heath JK; Leney AC
J Proteome Res; 2022 Apr; 21(4):930-939. PubMed ID: 35235327
[TBL] [Abstract][Full Text] [Related]
5. Proteogenomics approaches for studying cancer biology and their potential in the identification of acute myeloid leukemia biomarkers.
Hernandez-Valladares M; Vaudel M; Selheim F; Berven F; Bruserud Ø
Expert Rev Proteomics; 2017 Aug; 14(8):649-663. PubMed ID: 28693350
[TBL] [Abstract][Full Text] [Related]
6. Mass spectrometry-based proteomics analyses of post-translational modifications and proteoforms in human pituitary adenomas.
Li J; Zhan X
Biochim Biophys Acta Proteins Proteom; 2021 Mar; 1869(3):140584. PubMed ID: 33321259
[TBL] [Abstract][Full Text] [Related]
7. Proteomics of acute myeloid leukaemia: Cytogenetic risk groups differ specifically in their proteome, interactome and post-translational protein modifications.
Balkhi MY; Trivedi AK; Geletu M; Christopeit M; Bohlander SK; Behre HM; Behre G
Oncogene; 2006 Nov; 25(53):7041-58. PubMed ID: 16732326
[TBL] [Abstract][Full Text] [Related]
8. A Spin-Tip Enrichment Strategy for Simultaneous Analysis of N-Glycopeptides and Phosphopeptides from Human Pancreatic Tissues.
Tabang DN; Wang D; Li L
J Vis Exp; 2022 May; (183):. PubMed ID: 35604151
[TBL] [Abstract][Full Text] [Related]
9. The next level of complexity: crosstalk of posttranslational modifications.
Venne AS; Kollipara L; Zahedi RP
Proteomics; 2014 Mar; 14(4-5):513-24. PubMed ID: 24339426
[TBL] [Abstract][Full Text] [Related]
10. The Methods Employed in Mass Spectrometric Analysis of Posttranslational Modifications (PTMs) and Protein-Protein Interactions (PPIs).
Yakubu RR; Nieves E; Weiss LM
Adv Exp Med Biol; 2019; 1140():169-198. PubMed ID: 31347048
[TBL] [Abstract][Full Text] [Related]
11. dbPTM in 2019: exploring disease association and cross-talk of post-translational modifications.
Huang KY; Lee TY; Kao HJ; Ma CT; Lee CC; Lin TH; Chang WC; Huang HD
Nucleic Acids Res; 2019 Jan; 47(D1):D298-D308. PubMed ID: 30418626
[TBL] [Abstract][Full Text] [Related]
12. PTMscape: an open source tool to predict generic post-translational modifications and map modification crosstalk in protein domains and biological processes.
Li GXH; Vogel C; Choi H
Mol Omics; 2018 Jun; 14(3):197-209. PubMed ID: 29876573
[TBL] [Abstract][Full Text] [Related]
13. Substrate and Functional Diversity of Protein Lysine Post-translational Modifications.
Hao B; Chen K; Zhai L; Liu M; Liu B; Tan M
Genomics Proteomics Bioinformatics; 2024 May; 22(1):. PubMed ID: 38862432
[TBL] [Abstract][Full Text] [Related]
14. Investigation and identification of functional post-translational modification sites associated with drug binding and protein-protein interactions.
Su MG; Weng JT; Hsu JB; Huang KY; Chi YH; Lee TY
BMC Syst Biol; 2017 Dec; 11(Suppl 7):132. PubMed ID: 29322920
[TBL] [Abstract][Full Text] [Related]
15. Crosstalk between Ubiquitination and Other Post-translational Protein Modifications in Plant Immunity.
Zhang Y; Zeng L
Plant Commun; 2020 Jul; 1(4):100041. PubMed ID: 33367245
[TBL] [Abstract][Full Text] [Related]
16. Post-translational Modification Crosstalk and Hotspots in Sirtuin Interactors Implicated in Cardiovascular Diseases.
Aggarwal S; Banerjee SK; Talukdar NC; Yadav AK
Front Genet; 2020; 11():356. PubMed ID: 32425973
[TBL] [Abstract][Full Text] [Related]
17. Quantitative proteomic analysis of histone modifications in decitabine sensitive and resistant leukemia cell lines.
Zhang C; Suo J; Katayama H; Wei Y; Garcia-Manero G; Hanash S
Clin Proteomics; 2016; 13():14. PubMed ID: 27382363
[TBL] [Abstract][Full Text] [Related]
18. Post-translational quantitation by SRM/MRM: applications in cardiology.
Gianazza E; Banfi C
Expert Rev Proteomics; 2018 Jun; 15(6):477-502. PubMed ID: 29865883
[TBL] [Abstract][Full Text] [Related]
19. Crosstalk of intracellular post-translational modifications in cancer.
Wu Z; Huang R; Yuan L
Arch Biochem Biophys; 2019 Nov; 676():108138. PubMed ID: 31606391
[TBL] [Abstract][Full Text] [Related]
20. Utilizing a Comprehensive Immunoprecipitation Enrichment System to Identify an Endogenous Post-translational Modification Profile for Target Proteins.
Horita H; Law A; Middleton K
J Vis Exp; 2018 Jan; (131):. PubMed ID: 29364248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
